The bioengineered nanoparticles leverage the high-affinity interaction between PM-bound P-selectin and tumor cell CD44 receptors to specifically capture and clear CTCs in the blood and lymphatic circulation, significantly suppressing tumor metastasis [118]. The gene discussed is SELP; the disease is neoplasm.